Back to Search Start Over

ALBI Grade Is a Predictive Factor of Lenvatinib Treatment Discontinuation due to Adverse Events in Hepatocellular Carcinoma

Authors :
DAICHI ENOMOTO
KAZUHIRO YAMAMOTO
YUKI MATSUMOTO
ASAMI MORIOKA
TOMOHIRO OMURA
SHOHEI KOMATSU
YOSHIHIKO YANO
TAKUMI FUKUMOTO
IKUKO YANO
Source :
Anticancer Research. 43:1317-1323
Publication Year :
2023
Publisher :
Anticancer Research USA Inc., 2023.

Subjects

Subjects :
Cancer Research
Oncology
General Medicine

Details

ISSN :
17917530 and 02507005
Volume :
43
Database :
OpenAIRE
Journal :
Anticancer Research
Accession number :
edsair.doi...........1d0332abeebd5f7b63bf71145066e6c3

Tools

Authors Abstract Subjects Details